Article Collection

Lung Cancer

ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
Pan Y., Zhang Y., Li Y., Hu H., Wang L., Li H., Wang R., Ye T., Luo X., Zhang Y., Li B., Cai D., Shen L., Sun Y., Chen H.

On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
Mescam-Mancini L., Lantuejoul S., Moro-Sibilot D., Rouquette I., Souquet P.-J., Audigier-Valette C., Sabourin J.-C., Decroisette C., Sakhri L., Brambilla E., McLeer-Florin A.

Immunotherapy in the treatment of non-small cell lung cancer
Sundar R., Soong R., Cho B.-C., Brahmer J.R., Soo R.A.

Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation
Perez C.A., Velez M., Raez L.E., Santos E.S.

Cancer Treatment Reviews

Osteosarcoma treatment - Where do we stand? A state of the art review
Luetke A., Meyers P.A., Lewis I., Juergens H.

ALK inhibitors in the treatment of advanced NSCLC
Gridelli C., Peters S., Sgambato A., Casaluce F., Adjei A.A., Ciardiello F

Tumour-stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies
Heinemann V., Reni M., Ychou M., Richel D.J., Macarulla T., Ducreux M.

HER2 aberrations in cancer: Implications for therapy
Yan M., Parker B.A., Schwab R., Kurzrock R.

International Journal of Radiation Oncology, Biology, Physics

Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis
Arjun Sahgal, MD, Hidefumi Aoyama, MD, PhD, Martin Kocher, MD, Binod Neupane, PhD, Sandra Collette, PhD‖, Masao Tago, MD, Prakesh Shaw, MD, Joseph Beyene, PhD, Eric L. Chang, MD

Practical Radiation Oncology

Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer center network
Malolan S. Rajagopalan, MD, John C. Flickinger, MD, Dwight E. Heron, MD, Sushil Beriwal

Medical Dosimetry

Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy
X. Sharon Qi, Ph.D., Tian X. Liu, Ph.D., Arthur K. Liu, M.D., Ph.D., Francis Newman, M.S., Rachel Rabinovitch, M.D., Brian Kavanagh, M.D., Y. Angie Hu, Ph.D

Seminars in Radiation Oncology

Management of High-Grade Gliomas in the Elderly
Michelle Ferguson, MD, FRCPC, George Rodrigues, MD, PhD,  Jeffrey Cao, MD, MBA, FRCPC, Glenn Bauman, MD, FRCPC

Translational Oncology

Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study
Agata I. Rembielak, Pooja Jain, Andrew S. Jackson, Melanie M. Green, Gillian R. Santorelli, Gillian A. Whitfield, Adrian Crellin, Angel Garcia-Alonso, Ganesh Radhakrishna, James Cullen, M. Ben Taylor, Ric Swindell, Catharine M. West, Juan Valle, Azeem Saleem, Patricia M. Price


Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression
Chong-Sheng Chen3, Joshua C. Doloff3, David J. Waxman

European Journal of Oncology Nursing

A clinical randomized controlled trial of music therapy and progressive muscle relaxation training in female breast cancer patients after radical mastectomy: Results on depression, anxiety and length of hospital stay
Zhou, K.; Li, X.; Li, J.; Liu, M.; Dang, S.; Wang, D.; Xin, X.

Children's participation in shared decision-making: Children, adolescents, parents and healthcare professionals'perspectives and experiences
Coyne, I.; Amory, A.; Kiernan, G.; Gibson, F.

Searching for the new normal: Exploring the role of language and metaphors in becoming a cancer survivor
Lynda Appleton Maria Flynn

The effects of a six-week supervised multimodal exercise intervention during chemotherapy on cancer-related fatigue
Andersen, C.; Rorth, M.; Ejlertsen, B.; Stage, M.; Moller, T.; Midtgaard, J.; Quist, M.; Bloomquist, K.; Adamsen, L.

Patients’ and doctors’ preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
P. Blinman, B. Hughes, C. Crombie et al

Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression
I. Puzanov, R.K. Amaravadi, G.A. McArthur et al

Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries
A. Anttila, S. Lonnberg, A. Ponti et al.

The Breast

New approaches for improving outcomes in breast cancer in Europe
A. Di Leo, G. Curigliano, V. Dieras et al.

European Journal of Surgical Oncology

Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes
C. Bonneau, D. Hequet, J.P. Estevez et al.

Squamous cell carcinoma of the rectum: The treatment paradigm
D. Musio, F. De Felice, S. Manfrida et al.

Radiotherapy & Oncology

PET-CT use and the occurrence of elective nodal failure in involved field radiotherapy for non-small cell lung cancer: A systematic review
L. Kepka, J. Socha

Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons
A.V. Louie, D.A. Palma, M. Dahele et al.

Gynecologic Oncology

Comprehensive care in gynecologic oncology: The importance of palliative care
L.M. Landrum, S. Blank, L.-M. Chen et al

Cancer Epidemiology

Risk of oesophageal cancer among patients previously hospitalised with eating disorder
D.H. Brewster, S.L. Nowell, D.N. Clark

Journal of Cancer Policy

Equity of access to treatment on the cancer drugs fund: A missed opportunity for cancer research?
C. Chamberlain, S.M. Collin, L. Hounsome et al.


Whole prostate D90 and V100: A dose-response analysis of 2000 consecutive 125I monotherapy patients
W. James Morris, Ingrid Spadinger, Mira Keyes, Jeremy Hamm, Michael McKenzie, Tom Pickles

Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
Israel Deutsch, Michael J. Zelefsky, Zhigang Zhang, Qianxing Mo, Marco Zaider, Gil’ad Cohen, Oren Cahlon, Yoshiya Yamada

Clinical Oncology

Clinical features of radiation-induced carotid atherosclerosis
Gujral D.M., Shah B.N., Chahal N.S., Senior R., Harrington K.J., Nutting C.M.

The Effects of Pelvic Radiotherapy on Cancer Survivors: Symptom Profile, Psychological Morbidity and Quality of Life
Adams E., Boulton M.G., Horne A., Rose P.W., Durrant L., Collingwood M., Oskrochi R., Davidson S.E., Watson E.K.

Bortezomib in multiple Myeloma: A practice guideline
Kouroukis C.T., Baldassarre F.G., Haynes A.E., Imrie K., Reece D.E., Cheung M.C.

Current and investigational drug strategies for glioblastoma
Ajaz M., Jefferies S., Brazil L., Watts C., Chalmers A.